4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-003498
Co-Chief Executive Officer gave up 2,057 shares (to pay taxes)
- Co-Chief Executive Officer acquired 4,687 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-01-10 | Option exercise | +4,687 | 97,309 | D: show line 1 in the form | ||
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-01-10 | Shares withheld for taxes | −2,057 | $2.68 | $5,513 | 95,252 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-01-10 | Option exercise · Restricted Stock Units | −4,687 | 42,188 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…